Granulocyte macrophage colony-stimulating factor in 66 patients with myeloid or lymphoid neoplasms and recipients of hematopoietic stem cell transplantation with invasive fungal disease

Acta Haematologica

Volumn 129, Issue 1, 2013, Pages 26-34

  Safdar, Amar ^a,b   Rodriguez, Gilhen ^a   Zuniga, Jorge ^a   Al Akhrass, Fadi ^a   Georgescu, Georgia ^a   Pande, Anupam ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Combination antifungal agents; Granulocyte macrophage colony stimulating factor; Immune suppression; Invasive fungal disease; Leukemia; Stem cell transplant

Indexed keywords

CORTICOSTEROID; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; ANTIFUNGAL AGENT; PREDNISONE;

ADOLESCENT; ADULT; AGED; ARTICLE; BONE PAIN; CANCER CHEMOTHERAPY; CAPILLARY LEAK SYNDROME; CHILD; CORTICOSTEROID THERAPY; DISEASE SEVERITY; DRUG ERUPTION; DRUG MEGADOSE; FEMALE; FEVER; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; INTENSIVE CARE; INVASIVE ASPERGILLOSIS; LEUKEMIA RELAPSE; LYMPHATIC LEUKEMIA; MAJOR CLINICAL STUDY; MALE; MYALGIA; MYELOID LEUKEMIA; NEUTROPENIA; NONCARDIOGENIC LUNG EDEMA; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCHOOL CHILD; SYSTEMIC MYCOSIS; TREATMENT FAILURE; TREATMENT OUTCOME; TREATMENT RESPONSE; ZYGOMYCOSIS; ADJUVANT THERAPY; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; CANCER RECURRENCE; CAUSE OF DEATH; COMBINATION CHEMOTHERAPY; DRUG TREATMENT FAILURE; GRANULOCYTE TRANSFUSION; IMMUNOSUPPRESSIVE TREATMENT; LEUKEMIA; LYMPHOMA; RASH;

ADOLESCENT; ADRENAL CORTEX HORMONES; ADULT; AGED; AGED, 80 AND OVER; ANTIFUNGAL AGENTS; CHILD; FEMALE; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOCOMPROMISED HOST; LEUKEMIA, LYMPHOID; LEUKEMIA, MYELOID; MALE; MIDDLE AGED; MYCOSES; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84872080167     PISSN: 00015792     EISSN: 14219662     Source Type: Journal    
DOI: 10.1159/000342121     Document Type: Article

References (30)

1. Safdar A: Difficulties with fungal infections in acute myelogenous leukemia patients: Immune enhancement strategies. Oncologist 2007; 12(suppl 2):2-6
2. Safdar A: Strategies to enhance immune function in hematopoietic transplantation recipients who have fungal infections. Bone Marrow Transplant 2006; 38: 327-337
3. Safdar A: Immunomodulation therapy for invasive aspergillosis: Discussion on myeloid growth factors, recombinant cytokines and antifungal drug immune modulation. Curr Fungal Infect Rep 2010; 4: 1-7
4. Roilides E, Holmes A, Blake C, Venzon D, Pizzo PA, Walsh TJ: Antifungal activity of elutriated human monocytes against Aspergillus fumigatus hyphae: Enhancement by granulocyte-macrophage colony-stimulating factor and interferon-gamma. J Infect Dis 1994; 170: 894-899 (Pubitemid 24296569)
5. Roilides E, Blake C, Holmes A, Pizzo PA, Walsh TJ: Granulocyte-macrophage colonystimulating factor and interferon-gamma prevent dexamethasone-induced immunosuppression of antifungal monocyte activity against Aspergillus fumigatus hyphae. J Med Vet Mycol 1996; 34: 63-69
6. Gil-Lamaignere C, Simitsopoulou M, Roilides E, Maloukou A, Winn RM, Walsh TJ: Interferon-gamma and granulocyte-macrophage colony-stimulating factor augment the activity of polymorphonuclear leukocytes against medically important zygomycetes. J Infect Dis 2005; 191: 1180-1187 (Pubitemid 40404378)
7. Rodríguez MM, Calvo E, Mariné M, Pastor FJ, Fernandez-Ballart J, Guarro J: Efficacy of liposomal amphotericin B combined with gamma interferon or granulocyte-macrophage colony-stimulating factor for treatment of systemic zygomycosis in mice. Antimicrob Agents Chemother 2009; 53: 3569- 3571
8. Lamaris GA, Chamilos G, Lewis RE, Safdar A, Raad II, Kontoyiannis DP: Scedosporium infection in a tertiary care cancer center: A review of 25 cases from 1989-2006. Clin Infect Dis 2006; 43: 1580-1584
9. Safdar A, Papadopoulos EB, Young JW: Breakthrough Scedosporium apiospermum (Pseudallescheria boydii) brain abscess during therapy for invasive pulmonary aspergillosis following high-risk allogeneic hematopoietic stem cell transplantation. Scedosporiasis and recent advances in antifungal therapy. Transpl Infect Dis 2002; 4: 212-217 (Pubitemid 36142808)
10. Roilides E, Simitsopoulou M, Katragkou A, Walsh TJ: Host immune response against Scedosporium species. Med Mycol 2009; 47: 433-440
11. Lewis R, Hogan H, Howell A, Safdar A: Progressive fusariosis: Unpredictable posaconazole bioavailability, and feasibility of recombinant interferon-gamma plus granulocyte macrophage-colony stimulating factor for refractory disseminated infection. Leuk Lymphoma 2008; 49: 163-165 (Pubitemid 351146899)
12. Abzug MJ, Walsh TJ: Interferon-gamma and colony-stimulating factors as adjuvant therapy for refractory fungal infections in children. Pediatr Infect Dis J 2004; 23: 769-773 (Pubitemid 39063294)
13. Bandera A, Trabattoni D, Ferrario G, Cesari M, Franzetti F, Clerici M, Gori A: Interferongamma and granulocyte-macrophage colony stimulating factor therapy in three patients with pulmonary aspergillosis. Infection 2008; 36: 368-373
14. Dignani MC, Rex JH, Chan KW, Dow G, de Magalhaes-Silverman M, Maddox A, Walsh T, Anaissie E: Immunomodulation with interferon- gamma and colony-stimulating factors for refractory fungal infections in patients with leukemia. Cancer 2005; 104: 199- 204 (Pubitemid 40847769)
15. Bodey GP, Anaissie E, Gutterman J, Vadhan- Raj S: Role of granulocyte-macrophage colony- stimulating factor as adjuvant therapy for fungal infection in patients with cancer. Clin Infect Dis 1993; 17: 705-707 (Pubitemid 23293383)
16. Safdar A, Rodriguez GH, Lichtiger B, Dickey BF, Kontoyiannis DP, Freireich EJ, Shpall EJ, Raad II, Kantarjian HM, Champlin RE: Recombinant interferon - 1b immune enhancement in 20 patients with hematologic malignancies and systemic opportunistic infections treated with donor granulocyte transfusions. Cancer 2006; 106: 2664-2671
17. Ascioglu S, Rex JH, de Pauw B, Bennett JE, Bille J, Crokaert F, Denning DW, Donnelly JP, Edwards JE, Erjavec Z, Fiere D, Lortholary O, Maertens J, Meis JF, Patterson TF, Ritter J, Selleslag D, Shah PM, Stevens DA, Walsh TJ, Invasive Fungal Infections Cooperative Group of the European Organization for Research and Treatment of Cancer, Mycoses Study Group of the National Institute of Allergy and Infectious Diseases: Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: An international consensus. Clin Infect Dis 2002; 34: 7-14
18. Safdar A, Singhal S, Mehta J: Clinical significance of non- Candida fungal blood isolation in patients undergoing high-risk allogeneic hematopoietic stem cell transplantation (1993-2001). Cancer 2004; 100: 2456-2461
19. Safdar A, Rodriguez GH, De Lima MJ, Petropoulos D, Chemaly RF, Worth LL, Shpall EJ, Rolston KV, Raad II, Chan KW, Champlin RE: Infections in 100 cord blood transplantations: Spectrum of early and late posttransplant infections in adult and pediatric patients 1996-2005. Medicine 2007; 86: 324- 333
20. Safdar A, Hanna HA, Boktour M, Kontoyiannis DP, Hachem R, Lichtiger B, Freireich EJ, Raad II: Impact of high-dose granulocyte transfusions in patients with cancer with candidemia: Retrospective case-control analysis of 491 episodes of Candida species bloodstream infections. Cancer 2004; 101: 2859-2865 (Pubitemid 39603195)
21. Chemaly RF, Torres HA, Hachem R, Kontoyiannis DP, Safdar A, Raad II: Human herpesvirus- 6 DNAemia in immunosuppressed adult patients with leukemia at risk for mold infection. Haematologica 2008; 93: 157-158 (Pubitemid 351156173)
22. Rowe JM, Andersen JW, Mazza JJ, Bennett JM, Paietta E, Hayes FA, Oette D, Cassileth PA, Stadtmauer EA, Wiernik PH: A randomized placebo-controlled phase III study of granulocyte-macrophage colony-stimulating factor in adult patients (1 55 to 70 years of age) with acute myelogenous leukemia: A study of the Eastern Cooperative Oncology Group (E1490). Blood 1995; 86: 457-462
23. Verbeek W, Wörmann B, Koch P, Aul C, Hinrichs HF, Balleisen L, Rowe JM, Bennett J, Haase D, Fonatsch C, Heinecke A, Büchner T, Hiddemann W: Results of a randomized double-blind placebo-controlled trial evaluating sequential high-dose cytosine arabinoside/ mitoxantrone chemotherapy with or without granulocyte/macrophage-colonystimulating factor in high-risk myelodysplastic syndromes. J Cancer Res Clin Oncol 1999; 125: 369-374 (Pubitemid 29243113)
24. Heaney ML, Toy EL, Vekeman F, Laliberté F, Dority BL, Perlman D, Barghout V, Duh MS: Comparison of hospitalization risk and associated costs among patients receiving sargramostim, filgrastim, and pegfilgrastim for chemotherapy-induced neutropenia. Cancer 2009; 115: 4839-4848
25. Brummer E, Kamberi M, Stevens DA: Regulation by granulocyte-macrophage colonystimulating factor and/or steroids given in vivo of proinflammatory cytokine and chemokine production by bronchoalveolar macrophages in response to Aspergillus conidia. J Infect Dis 2003; 187: 705-709 (Pubitemid 36250039)
26. Choi JH, Brummer E, Kang YJ, Jones PP, Stevens DA: Inhibitor - B and nuclear factor - B in granulocyte-macrophage colony-stimulating factor antagonism of dexamethasone suppression of the macrophage response to Aspergillus fumigatus conidia. J Infect Dis 2006; 193: 1023-1028
27. Schmidt S, Tramsen L, Hanisch M, Latgé JP, Huenecke S, Koehl U, Lehrnbecher T: Human natural killer cells exhibit direct activity against Aspergillus fumigatus hyphae, but not against resting conidia. J Infect Dis 2011; 203: 430-435
28. Safdar A, Shelburne SA, Evans SE, Dickey BF: Inhaled therapeutics for prevention and treatment of pneumonia. Expert Opin Drug Saf 2009; 8: 435-449
29. Quezada G, Koshkina NV, Zweidler-McKay P, Zhou Z, Kontoyiannis DP, Kleinerman ES: Intranasal granulocyte-macrophage colonystimulating factor reduces the Aspergillus burden in an immunosuppressed murine model of pulmonary aspergillosis. Antimicrob Agents Chemother 2008; 52: 716-718 (Pubitemid 351170848)
30. Rao RD, Anderson PM, Arndt CA, Wettstein PJ, Markovic SN: Aerosolized granulocyte macrophage colony-stimulating factor (GMCSF) therapy in metastatic cancer. Am J Clin Oncol 2003; 26: 493-498 (Pubitemid 37248269)